CLINICAL SYMPTOMS OF ANXIETY DISORDERS IN PATIENTS WITH BASEDOW DISEASE

Quốc Trí Nguyễn1,2,, Doãn Phương Nguyễn3
1 Hanoi medical university
2 Vietnam national mental health institute
3 Construction Hospital

Main Article Content

Abstract

Objectives: Describe anxiety disorders clinical symptoms in patients with Basedow disease. Subjects and methods: Cross-sectional description of outpatients with Basedow disease at Outpatient Department - Bach Mai Hospital from August 2021 to October 2022. Results: 48.2% of Graves' outpatients suffer comorbid anxiety disorder. Autonomic arousal symptoms and other non-specific symptoms are the most common symptoms in this group of patients, encountered in 100% of patients. Symptoms of palpitations or pounding heart, or accelerated heart rate are the most common, occurring in 100% of patients. Other symptoms such as dizziness (95.1%), tremor (92.7%), difficulty in concentrating, or mind going blank, because of worrying or anxiety (90.2%), hot flushes or cold chills (87.8%), sweating (85.4%) is also common. In the majority of patients, these symptoms present to be mild to moderate. Conclusion: Anxiety disorder is a common disease associated with Basedow disease and shoud be noticed in this group of patients.

Article Details

References

1. Davies TF, Andersen S, Latif R, et al. Graves’ disease. Nat Rev Dis Primers. 2020;6(1):52. doi:10.1038/s41572-020-0184-y
2. Basedow’s coma. NORD (National Organization for Rare Disorders). https:// rarediseases.org/ gard-rare-disease/basedows-coma/
3. Fukao A, Takamatsu J, Arishima T, et al. Graves’ disease and mental disorders. Journal of Clinical & Translational Endocrinology. 2020; 19:100207. doi:10.1016/j.jcte.2019.100207
4. Zhu Jie, Jiang Yi, Ren Jianmin, et al. Anxiety and the Risk Factors in Graves' Disease. Chinese Journal of Mental Health. 2004;18(7):495-497.
5. Antonelli A, Ferrari SM, Ragusa F, et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best Practice & Research Clinical Endocrinology & Metabolism. 2020;34(1):101387. doi:10.1016/ j.beem.2020.101387
6. Chattopadhyay C, Chakrabarti N, Ghosh S. An assessment of psychiatric disturbances in Graves disease in a medical college in eastern India. Nigerian Journal of Clinical Practice. 2012;15(3):276-279. doi:10.4314/njcp.v15i3
7. Ubaidullaeva NB, Allayarova GI, Nasyrkhodzhaev YB, et al. The level of anxiety in women with Graves’ disease. Endocrinol Metab Int J. 2018;6(6):423-425. doi:10.15406/ emij.2018.06.00227